
Publications
Les travaux publiés par nos équipes et leurs partenaires académiques et industriels.

Consumption and exposure assessment to toothpaste in French families
Food and Chemical Toxicology, 2018.
The aim of the study was to assess the consumption and the exposure to toothpaste in French families leaving the consumers free to use their own product at home according to their habits. Consumption data were collected on 104 families. 206 adults (103 women and 103 men) and 195 children aged 2-17 participated in the study. Differences in toothpaste consumption depending on gender and on age were highlighted. The frequency of use and the amount of toothpaste used per application increased with age, while exposure to toothpaste decreased with age. Children aged 2-6 were the most exposed to toothpaste with a P95 value equal to 8.2 mg/kg bw/day; the adult P95 exposure value was equal to 2.8 mg/kg bw/day. These new data will be useful for safety assessors, especially children data which remain scarce.
Consulter la publication
Consumption and exposure assessment to sunscreen products: a key point for safety assessment
Food and Chemical Toxicology, 2018.
Étude de consommation et d'exposition aux produits solaires menée en conditions réelles d'utilisation, apportant des données essentielles au calcul de l'exposition consommateur lors de l'évaluation de la sécurité.
Consulter la publication
GABAA receptor activity modulating piperine analogs: in vitro metabolic stability, metabolite identification, CYP450 reaction phenotyping, and protein binding
Journal of Chromatography B, 2018.
In a screening of natural products for allosteric modulators of GABAA receptors, piperine was identified as a compound targeting a benzodiazepine-independent binding site. We investigated the metabolism of piperine and selected analogs. Metabolic stability was evaluated by incubation with pooled human liver microsomes, and metabolites were analyzed by UHPLC-Q-TOF-MS. CYP450 isoenzymes involved in the metabolism of the compounds were identified by reaction phenotyping with Silensomes™. Piperine was the metabolically most stable compound and was exclusively metabolized by CYP1A2, whereas CYP2C9 contributed significantly to the oxidative metabolism of all analogs.
Consulter la publication
Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ model
Y. Parmentier, C. Pothier, N. Hewitt, L. Vincent, F. Caradec, J. Liu, F. Lin, M.-M. Trancart, F. Guillet, B. Bouaita, C. Chesné & B. Walther, Xenobiotica, vol. 49, p. 22-35, 2018.
We have applied the concept of using MBIs to produce CYP-Silensomes to quantify the contribution of the major CYPs to drug metabolism (fmCYP). The target CYPs were extensively and selectively inhibited by the selected MBIs, while non-target CYPs were inhibited by less than 20% of the homologous control activities. To validate the use of a panel of 6 CYP-Silensomes, we showed that the fmCYP values of mono- and multi-CYP metabolised drugs were well predicted, with 70% within ±15% accuracy. These results support the use of CYP1A2-, CYP2B6-, CYP2C8-, CYP2C9-, CYP2D6- and CYP3A4-Silensomes to accurately predict fmCYP values during in vitro enzyme phenotyping assays.
Consulter la publication
Direct and quantitative evaluation of the human CYP3A4 contribution (fm) to drug clearance using the in vitro SILENSOMES model
Y. Parmentier, C. Pothier, A. Delmas, F. Caradec, M.-M. Trancart, F. Guillet, B. Bouaita, C. Chesné, J. B. Houston & B. Walther, Xenobiotica, vol. 47, p. 562-575, 2016.
Among the different in vitro studies recommended by the regulatory agencies, no gold-standard model can easily and directly measure the quantitative CYP450 contributions to drug biotransformation. In this article, we propose an original strategy, called Silensomes™, to produce human liver microsomes silenced for one specific CYP450, thanks to specific mechanism-based inhibitors (MBI). Using azamulin as a specific CYP3A4 MBI, we demonstrated the proof of concept that CYP3A4 can be totally, specifically and permanently inhibited by our process. This easy and ready-to-use in vitro method combines the advantages of existing models without their drawbacks.
Consulter la publication
